News
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
May 4, 2020
Two single-center reports further documented the incidence of QTc-interval prolongations in COVID-19 patients treated with hydroxychloroquine.
Opinion
COVID-19: To have and to hold … in quarantine
May 4, 2020
All of us can benefit from these skills, especially emotionally volatile couples who are trapped together in quarantine, Dr. Dara Abraham said.
News
FDA authorizes emergency use of remdesivir for COVID-19
May 2, 2020
The designation means remdesivir can be distributed in the United States and administered intravenously by healthcare providers, as appropriate, to treat severe disease.
News
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
May 1, 2020
Four provinces in northern Italy report increases of various magnitudes, ranging from 18% to a stunning 187%.
News
Excess cancer deaths predicted as care is disrupted by COVID-19
May 1, 2020
Researchers are predicting that, 1 year from now, there will be 33,890 excess deaths among cancer patients in the United States over the age of 40.
News
New tetracycline antibiotic effective in acute bacterial skin and skin-structure infections
May 1, 2020
Is omadacycline, a new tetracycline-class antibiotic, as effective as linezolid in the treatment of acute bacterial skin and skin-structure infections?
News
COVID-19: A ‘marathon, not a sprint’ for psychiatry
May 1, 2020
Providing emotional support will help individuals engage with instrumental supports, said Dr. Joshua Morganstein.
News
New study of diabetes drug for COVID-19 raises eyebrows
May 1, 2020
Some question the safety of AstraZeneca’s just-launched DARE-19 study testing whether dapagliflozin will reduce adverse outcomes of COVID-19.
News
Case series suggests biologics, JAK inhibitors safe during pandemic
May 1, 2020
Investigators saw no increase in hospitalizations versus the general population in New York City.
News
Antitumor treatment may increase risk of severe events in COVID-19 patients
May 1, 2020
Receiving antitumor treatment within 14 days of COVID-19 diagnosis was linked to a higher risk of ICU admission, mechanical ventilation, or death.